Results 61 to 70 of about 694 (158)

Development and characterization of bilastine nanosuspension for enhanced dissolution in orodispersible films

OpenNano
Bilastine, a second-generation antihistamine, is commonly prescribed for managing allergic rhinoconjunctivitis and urticaria due to its prolonged action.
Sarah Adnan Oudah, Eman B.H. Al-Khedairy
doaj   +1 more source

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

Therapeutics and Clinical Risk Management, 2016
Xue Yan Wang,1 Margaret Lim-Jurado,2 Narayanan Prepageran,3 Pongsakorn Tantilipikorn,4 De Yun Wang5 1Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2St Luke’s Medical Center,
Wang XY, Lim-Jurado M, Prepageran N, Tantilipikorn P, Wang DY   +4 more
doaj  

Application of physiologically‐based pharmacokinetic modeling to inform dosing decisions for geriatric patients

CPT: Pharmacometrics &Systems Pharmacology, Volume 13, Issue 12, Page 2031-2035, December 2024.
Lixuan Qian, Ziteng Wang, Mary F. Paine, Eric Chun Yong Chan, Zhu Zhou   +4 more
wiley   +1 more source

New possibilities for symptomatic treatment of allergic rhinitis

Медицинский совет, 2019
Allergic rhinitis is one of the most common human diseases and causes a deterioration of the quality of life. The prevalence of allergic rhinitis in the Russian Federation and in the world has increased significantly.
S. V. Ryazantsev, A. A. Krivopalov, S. A. Rebrova, L. I. Krivopalova   +3 more
doaj   +1 more source

Comparison of the Efficacy and Safety of Levocetirizine versus Bilastine for the Treatment of Chronic Spontaneous Urticaria in the Pediatric Population: An Observer-blinded Randomized Control Trial

Indian Journal of Paediatric Dermatology
Background: Chronic spontaneous urticaria (CSU) refers to urticaria that has no specific cause or trigger, present on most days of the week for 6 weeks or more.
Debashree Sahoo, Maitreyee Panda, Ajaya Kumar Jena, Anil Kumar Panda   +3 more
doaj   +1 more source

Bilastine and quality of life.

Journal of investigational allergology & clinical immunology, 2012
The evaluation of quality of life (QoL) and its modification through therapeutic interventions has become a prioritary concern in recent years and a requirement on the part of regulatory agencies for the authorization of new drugs. In clinical studies of allergic disorders, particularly allergic rhinitis and urticaria, different types of generic ...
I, Jáuregui, J, Bartra, A, del Cuvillo, I, Dávila, M, Ferrer, J, Montoro, J, Mullol, J, Sastre, A, Valero   +8 more
openaire   +1 more source

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria

Therapeutics and Clinical Risk Management, 2013
Belen Sadaba, Jose Ramon Azanza, Almundena Gomez-Guiu, Raquel RodilClinical Pharmacology Service, Clinica Universidad de Navarra, Navarra, SpainAbstract: Bilastine is a second generation antihistamine indicated for the treatment of seasonal or perennial ...
Sadaba B, Azanza JR, Gomez-Guiu A, Rodil R   +3 more
doaj  

A perception-based survey to understand the role of a combination of bilastine and montelukast in the management of allergic rhinitis

The Journal of Association of Chest Physicians
Aim: To understand the clinical perceptions and role of a combination of bilastine and montelukast in the management of allergic rhinitis (AR). Methods: A cross-sectional, observational survey was conducted through a digital questionnaire among 445 ...
Vikrant Deshmukh, Mahavir Bagrecha, Sanjay Sathe, Swapnil Kadam, G. Gananathan, Carlton Periera, Vaishali Gupte, Gurmeet Kaur Thakur, Manjushree Naik Patil   +8 more
doaj   +1 more source

Development of expeditious RP-HPLC method for simultaneous estimation of bilastine and montelukast in fixed dosage combination

Journal of Applied Pharmaceutical Research
Background: Bilastine and montelukast are used to treat allergic rhinitis and chronic urticaria. Due to the recent increase in highly allergic disorders, demand for this combination has risen. Therefore, for regular quality control analysis, a new, rapid,
Revathi Boddu, Jithendar Reddy Mandhadi, Narender Boggula, Rajeshwar Vodeti, Suchitra Duddagi   +4 more
doaj   +1 more source

Balanced discussion of second-generation antihistamines' data

Therapeutics and Clinical Risk Management, 2016
Rossen Boev,1 Jürgen WG Bentz2 1UCB Pharma, Bulle, Switzerland; 2UCB Pharma, Brussels, Belgium It is with interest that we read the paper “Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine ...
Boev R, Bentz JWG
doaj